| Literature DB >> 32082531 |
K Mertens1, J Muys2, Y Jacquemyn2,3.
Abstract
BACKGROUND: During pregnancy the maternal immune system adjusts to preserve the foetoplacental unit. These adjustments lead to an increase in CRP, continuing into the postpartum. The objective of this study was to determineantepartal, peripartal and postpartal factors associated with an elevated CRP on the second postpartum day.Entities:
Keywords: C-reactive protein; CRP; endometritis; epidural anesthesia; infection; postpartum
Year: 2019 PMID: 32082531 PMCID: PMC7020948
Source DB: PubMed Journal: Facts Views Vis Obgyn ISSN: 2032-0418
— Maternal Characteristics.
| Maternal characteristics (N=1400) | Mean (±SD) - % |
|---|---|
| Age | 30,20 (±5,00) |
| Parity | 1,90 (±1,11) |
| Gestational age | 37,76 (±3,39) |
| BMI | 24,07 (±4,66) |
| Twin (n=62) | 4,4% |
| Infection | |
| 1. HIV (n=18) | 1,3% |
| 2. Hepatitis B (n=3) | 0,2% |
| 3. Hepatitis C (n=4) | 0,3% |
| 5. HIV + Hepatitis C (n=1) | 0,1% |
| 6. Others (n=8) | 0,6% |
Abbreviations: BMI: body mass index, HIV: human immune deficiency virus.
— Overview of antepartal, perpartal and postpartal factors in the population.
| Antepartal factors (N=1400) | Mean (±SD) - % | Length of admission till childbirth | 8,51 (±8,61) |
|---|---|---|---|
| Number of vaginal examinations | 3,81 (±3,16) | Diabetes | |
| ROM | 1. No diabetes (n=1322) | 94,5% | |
| 1. Spontaneous (n=564) | 40,9% | 2. Gestational diabetes (n=55) | 3,9% |
| 2. Artificial (n=526) | 38,1% | 3. Diabetes type 1 (n=15) | 1,1% |
| 3. Artificial during caesarean (n=289) | 21,0% | 4. Diabetes type 2 (n=7) | 0,5% |
| Interval between ROM and fetal expulsion (hours) | 4,97 (±13,30) | Peripartal factors (N=1400) | Mean (±SD) - % |
| Fever (≥ 38,0°C) (n=39) | 3,1% | Way of childbirth | |
| Number of urinary catheterisations | 0,40 (±0,73) | 1. Spontaneous delivery (n=809) | 57,9% |
| Indwelling urinary catheter (n=448) | 34,9% | 2. Assisted vaginal delivery (n=148) | 10,6% |
| GBS status | 3. Planned caesarean (n=280) | 20,0% | |
| 1. No carrier (n=968) | 69,8% | 4. Caesarean in labour (n=161) | 11,5% |
| 2. Carrier (n=212) | 15,3% | ||
| 3. Unknown (n=206) | 14,9% | ||
| GBS prophylaxis (n=231) | Perineum | ||
| when GBS positive or unknown | 55,26% | 1. Intact (n=692) | 49,5% |
| Antibiotics (AB) labor/caesarean | 2. First degree rupture (n=234) | 16,7% | |
| 1. No antibiotics (n=792) | 59,00% | 3. Second degree rupture (n=212) | 15,2% |
| 2. Penicillin (n=222) | 16,50% | 4. Third degree rupture (n=10) | 0,7% |
| 3. Clindamycin (n=18) | 1,30% | 5. Fourth degree rupture (n=5) | 0,4% |
| 4. Cefuroxim (n=100) | 7,40% | 6. Episiotomy (n=238) | 17,0% |
| 5. Cefazolin (n=193) | 14,40% | 7. Episiotomy and rupture (n=7) | 0,5% |
| 6. Penicillin + cefuroxim (n=9) | 0,70% | Postpartal factors (N=1400) | Mean (±SD) - % |
| 7. Others (n=9) | 0,70% | Feeding | |
| Number of doses of AB (n=1327) | 0,56 (±0,90) | 1. Breastfeeding (n=1129) | 81,0% |
| Analgesia | 2. Formula feeding (n=253) | 18,2% | |
| 1. No analgesia (n=427) | 30,7% | 3. Breast- and formula feeding (n=11) | 0,8% |
| 2. Epidural analgesia (n=905) | 65,1% | Fever (≥38,0°C) (n=19) | 1,4% |
| 3. General analgesia (n=48) | 3,5% | Placental delivery | |
| 4. Epidural + general (n=11) | 0,8% | 1. Spontaneous (n=939) | 67,1% |
| WBC on day of delivery (.10^3/ml) | 11,91 (±3,68) | 2. Manual removal (n=461) | 32,9% |
| Intravenous line (n=1130) | 81,2% | Endomyometritis (n=6) | 0,4% |
| Fetal scalp electrode (n=358) | 25,6% | Wound infection (n=9) | 0,6% |
| Situation on admission in the delivery ward | Phlebitis (n=1) | 0,1% | |
| 1. Spontaneous labor (n=729) | 52,2% | Cystitis (n=4) | 0,3% |
| 2. Induction with ballon and vaginal prostaglandin alone (n=214) | 15,3% | Antibiotics postpartum (n=22) | 1,6% |
| 3. Induction with vaginal prostaglandin alone (n=78) | 5,6% | Type antibiotics postpartum (n=1397) | |
| 4. Previously hospitalized in MIC (n=232) | 16,6% | 1. amoxycilline-clavulanic acid (n=15) | 1,1% |
| 5. Planned caesarean (n=144) | 10,3% | 2. Penicillin (n=5) | 0,4% |
| Blood pressure | 3. Others (n=3) | 0,2% | |
| 1. Normotensive (n=1280) | 91,5% | WBC on day 2 after delivery (.10^3/ml) | 11,38 (±3,10) |
| 2. Essential hypertension (n=11) | 0,8% | CRP day 2 postpartum (mg/L) | 5,98 (±4,97) |
| 3. Gestational hypertension (n=28) | 2,0% | ||
| 4. Pre-eclampsia (n=54) | 3,9% | ||
| 5. Eclampsia (n=2) | 0,1% | ||
| 6. HELLP (n=24) | 1,7% |
Abbreviations: ROM: rupture of membranes, WBC: white blood cell count, MIC: maternal intensive care, a dedicated ward for observation and treatment of problems during pregnancy e.g. preeclampsia, preterm labour. HELLP: hemolysis, elevated liver tests, low platelets, GBS: group B streptococci, AB: antibiotics.
— Differences in CRP value within antepartal, perpartal and postpartal factors.
| mean CRP (mg/L) ±SD | p | |
|---|---|---|
| ROM† | <0,001 | |
| 1. Spontaneaous (n=564) | 4,75 ±4,26 | |
| 2. Artificial (n=526) | 5,13 ±4,47 | |
| 3. Artificial during cesarean (n=289)* | 10,05 ±5,07 | |
| Fever (≥ 38,0°C) (n=39)‡ | 9,69 ±5,39 | <0,001 |
| Indwelling catheter (n=448)‡ | 10,69 ±5,27 | <0,001 |
| GBS status† | <0,001 | |
| 1. No carrier (n=968) | 5,66 ±4,65 | |
| 2. Carrier (n=212) | 5,23 ±4,91 | |
| 3. Unknown (n=206)* | 8,06 ±5,77 | |
| Analgesia† | <0,001 | |
| 1. No analgesia (n=427) | 2,87 ±1,90 | |
| 2. Epidural analgesia (n=905)* | 7,28 ±5,27 | |
| 3. General analgesia (n=48)* | 8,08 ±5,50 | |
| 4. Epidural and general (n=11)* | 12,09 ±2,74 | |
| Intravenous line (n=1130)‡ | 6,72 ±5,19 | <0,001 |
| Scalp electrode (n=358)‡ | 6,54 ±4,96 | <0,001 |
| Situation on admission in the delivery ward† | <0,001 | |
| 1. Spontaneous labor (n=729) | 4,58 ±3,96 | |
| 2. Induction with ballon and vaginal prostaglandin (n=214) | 6,35 ±4,97 | |
| 3. Induction with vaginal prostaglandin alone (n=78) | 5,36 ±4,59 | |
| 4. Previously hospitalized in MIC (n=232) | 7,34 ±5,94 | |
| 5. Planned caesarean (n=144)* | 10,57 ±4,59 | |
| Blood pressure† | 0,182 | |
| 1. Normotensive (n=1280) | 5,91 ±4,98 | |
| 2. Essential hypertension (n=11) | 7,86 ±5,98 | |
| 3. Gestational hypertension (n=28) | 5,91 ±4,92 | |
| 4. Pre-eclampsia (n=54) | 6,92 ±4,68 | |
| 5. Eclampsia (n=2) | 5,62 ±4,79 | |
| 6. HELLP (n=24) | 6,91 ±4,17 | |
| Diabetes† | 0,017 | |
| 1. No diabetes (n=1322) | 5,88 ±4,91 | |
| 2. Gestational diabetes (n=55)* | 7,94 ±5,95 | |
| 3. Diabetes type 1 (n=15)* | 7,41 ±4,55 | |
| 4. Diabetes type 2 (n=7)* | 6,96 ±4,43 | |
| Delivery† | <0,001 | |
| 1. Spontaneous vaginal (n=809) | 3,45 ±2,55 | |
| 2. Assisted vaginal (n=148) | 5,44 ±3,22 | |
| 3. Primary caesarean (n=280)* | 9,92 ±5,09 | |
| 4. Secondary caesarean without labor (n=23)* | 9,50 ±5,68 | |
| 5. Secondary caesarean with labor (n=138)* | 12,87 ±4,99 | |
| Perineum† | <0,001 | |
| 1. Intact (n=692)* | 8,11 ±5,80 | |
| 2. First degree laceration (n=234) | 3,34 ±2,43 | |
| 3. Second degree laceration (n=212) | 3,56 ±2,23 | |
| 4. Third degree laceration (n=10) | 5,25 ±3,75 | |
| 5. Fourth degree laceration (n=5) | 3,44 ±3,11 | |
| 6. Episiotomy (n=238) | 4,61 ±2,96 | |
| 7. Episiotomy and laceration (n=7) | 6,79 ±3,50 | |
| Feeding† | 0,030 | |
| 1. Breastfeeding (n=1129) | 5,79 ±4,84 | |
| 2. Formula feeding (n=253)* | 6,75 ±5,36 | |
| 3. Breast and formula feeding (n=11) | 6,18 ±5,10 | |
| Fever postpartum (≥38,0°C) (n=19)‡ | 12,07 ±8,09 | <0,001 |
| Placenta‡ | <0,001 | |
| 1. Spontaneous expulsion (n=939) | 3,83 ±3,03 | |
| 2. Manual removal (n=461)* | 10,34 ±5,27 | |
| Twin (n=62)‡ | 8,37 ±5,87 | <0,001 |
| Infection (n=34)‡ | 7,99 ±6,92 | 0,074 |
| Endomyometritis (n=6)‡ | 11,10 ±7,32 | 0,024 |
| Wound infection (n=9)‡ | 8,86 ±5,08 | 0,031 |
| Phlebitis (n=1)‡ | 7,90 | 0,437 |
| Cystitis (n=4)‡ | 11,80 ±5,19 | 0,024 |
Abbreviations: ROM: rupture of membranes, MIC: maternal intensive care, HELLP: hemolysis, elevated liver tests, low platelets.
* Group with significant elevation of CRP value; † Kruskal-Wallis; ‡ Mann-Whitney U.
Figure 1Distribution of CRP value in the research sample, vertical axis represents number of cases.
— Univariate and multivariate factors related to higher CRP on day 2 postpartum.
| Univariate | Multiple linear regression† | |||||
|---|---|---|---|---|---|---|
| Independent variables (N=1400) | rs | p | B | β | p | |
| Age (n=1400) | 0,012 | 0,651 | ||||
| Parity (n=1393) | -0,178 | <0,001 | 0,159 | 0,036 | 0,091 | |
| Gestational age (n=1389) | -0,119 | <0,001 | 0,122 | 0,081 | 0,002 | |
| BMI (n=1208)° | 0,163 | <0,001 | ||||
| Number of vaginal examinations (n=1246)° | -0,134 | <0,001 | ||||
| Interval between ROM and fetal expulsion (n=1256) | -0,028 | 0,329 | ||||
| Number of bladder catheterisations (n=1251) | 0,024 | 0,395 | ||||
| WBC on day of delivery (n=1400) | 0,008 | 0,774 | ||||
| Duration admission till birth (n=1367) | -0,039 | 0,147 | ||||
| WBC 2 postpartum (n=1400) | 0,252 | <0,001 | 0,323 | 0,200 | <0,001 | |
| R | R2 | |||||
| Amnioyomy during caesarean (n=289) | 0,418 | 0,175 | <0,001 | 1,770 | 0,146 | <0,001 |
| Fever during labor (n=39) | 0,127 | 0,016 | <0,001 | 2,999 | 0,103 | <0,001 |
| Indwelling catheter (n=448) | 0,652 | 0,425 | <0,001 | 2,396 | 0,226 | 0,008 |
| GBS unknown (n=206) | 0,178 | 0,032 | <0,001 | 0,233 | 0,017 | 0,435 |
| Any analgesia (n=964) | 0,418 | 0,174 | <0,001 | 1,387 | 0,126 | <0,001 |
| Intravenous line (n=1130) | 0,301 | 0,090 | <0,001 | 0,235 | 0,018 | 0,524 |
| Scalp electrode (n=358) | 0,066 | 0,004 | 0,014 | 0,933 | 0,082 | <0,001 |
| Planned caesarean (n=144) | 0,314 | 0,099 | <0,001 | 1,084 | 0,068 | 0,019 |
| Diabetes (n=77) | 0,086 | 0,007 | 0,001 | 0,441 | 0,020 | 0,321 |
| Intact perineum (n=692) | 0,424 | 0,180 | <0,001 | 0,167 | 0,017 | 0,556 |
| Any caesarean (n=441) | 0,658 | 0,434 | <0,001 | 5,216 | 0,489 | <0,001 |
| Formula feeding (n=253) | 0,074 | 0,006 | 0,006 | 0,551 | 0,043 | 0,030 |
| Fever during postpartum (n=19) | 0,144 | 0,021 | <0,001 | 3,458 | 0,074 | 0,001 |
| Manual removal of placenta (n=461) | 0,616 | 0,380 | <0,001 | 0,245 | 0,023 | 0,665 |
| Twin (n=62) | 0,104 | 0,011 | <0,001 | 0,150 | 0,006 | 0,762 |
| Endomyometritis (n=6) | 0,068 | 0,005 | 0,011 | 1,145 | 0,013 | 0,524 |
| Wound infection (n=9) | 0,047 | 0,002 | 0,081 | 1,745 | 0,030 | 0,142 |
| Cystitis (n=4) | 0,063 | 0,004 | 0,019 | 4,583 | 0,026 | 0,197 |
| R2 = 0,551 | Adjusted R2 = 0,543 | |||||
Abbreviations: R: correlation coefficient, R2 coefficient of detremination, RS: Spearman’s rank, B, ROM: rupture of membranes, BMI: body mass index, WBC: white blood cell count; GBS: group B streptococci.
°BMI and number of vaginal examinations were not further analyzed because of > 10% missing data.